Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:HYBTNASDAQ:HYPRNASDAQ:ICCMOTCMKTS:RDGL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHYBTHeyu Biological Technology$0.14$0.16$0.00▼$3.40$14.15M-17.745,371 shsN/AHYPRHyperfine$0.74+1.4%$0.70$0.53▼$1.90$56.91M0.95901,773 shs206,167 shsICCMIceCure Medical$1.01-0.5%$1.05$0.48▼$1.66$56.33M0.33477,454 shs208,123 shsRDGLAdvanced Medical Isotope$0.12+0.8%$0.13$0.06▼$0.23$53.97M1.06472,516 shs271,653 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHYBTHeyu Biological Technology0.00%+45,566.67%-32.35%-11.61%-31.53%HYPRHyperfine+1.42%+6.89%+24.03%+3.00%-11.45%ICCMIceCure Medical-0.49%+6.18%-1.94%-9.01%+35.70%RDGLAdvanced Medical Isotope+0.84%-2.04%-9.09%-1.56%-36.84%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHYBTHeyu Biological TechnologyN/AN/AN/AN/AN/AN/AN/AN/AHYPRHyperfine2.6071 of 5 stars3.32.00.00.02.72.50.6ICCMIceCure Medical2.6134 of 5 stars3.84.00.00.02.00.00.6RDGLAdvanced Medical IsotopeN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHYBTHeyu Biological Technology 0.00N/AN/AN/AHYPRHyperfine 2.67Moderate Buy$1.0642.93% UpsideICCMIceCure Medical 3.50Strong Buy$2.50147.52% UpsideRDGLAdvanced Medical Isotope 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest HYBT, HYPR, RDGL, and ICCM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/3/2025HYPRHyperfineB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/29/2025ICCMIceCure MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$2.505/15/2025HYPRHyperfineB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$1.20 ➝ $1.005/14/2025HYPRHyperfineWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$1.29 ➝ $0.683/28/2025ICCMIceCure MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$2.50 ➝ $2.50(Data available from 6/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHYBTHeyu Biological Technology$80K176.81N/AN/A$0.38 per share0.36HYPRHyperfine$12.89M4.48N/AN/A$0.67 per share1.11ICCMIceCure Medical$3.29M17.04N/AN/A$0.12 per share8.42RDGLAdvanced Medical Isotope$30K1,814.04N/AN/A($0.02) per share-6.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHYBTHeyu Biological Technology-$270KN/A0.00∞N/A-453.55%-6.43%-4.43%N/AHYPRHyperfine-$40.72M-$0.54N/AN/AN/A-343.42%-74.19%-62.40%8/6/2025 (Estimated)ICCMIceCure Medical-$15.32M-$0.28N/AN/AN/A-467.37%-182.26%-112.65%8/19/2025 (Estimated)RDGLAdvanced Medical Isotope-$2.91M-$0.01N/A∞N/A-6,249.02%N/A-149.07%8/11/2025 (Estimated)Latest HYBT, HYPR, RDGL, and ICCM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/28/2025Q1 2025ICCMIceCure Medical-$0.08-$0.06+$0.02-$0.06$0.75 million$0.73 million5/13/2025Q1 2025HYPRHyperfine-$0.12-$0.12N/A-$0.12$2.82 million$2.14 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHYBTHeyu Biological TechnologyN/AN/AN/AN/AN/AHYPRHyperfineN/AN/AN/AN/AN/AICCMIceCure MedicalN/AN/AN/AN/AN/ARDGLAdvanced Medical IsotopeN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHYBTHeyu Biological TechnologyN/A0.350.34HYPRHyperfineN/A6.075.48ICCMIceCure Medical0.021.891.48RDGLAdvanced Medical IsotopeN/A28.6228.43Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHYBTHeyu Biological TechnologyN/AHYPRHyperfine15.03%ICCMIceCure Medical0.62%RDGLAdvanced Medical IsotopeN/AInsider OwnershipCompanyInsider OwnershipHYBTHeyu Biological Technology89.24%HYPRHyperfine30.98%ICCMIceCure Medical2.44%RDGLAdvanced Medical Isotope18.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHYBTHeyu Biological Technology6103.25 million11.11 millionNot OptionableHYPRHyperfine19077.83 million53.72 millionOptionableICCMIceCure Medical6055.50 million54.15 millionNot OptionableRDGLAdvanced Medical Isotope1453.51 million369.61 millionNot OptionableHYBT, HYPR, RDGL, and ICCM HeadlinesRecent News About These CompaniesVivos (OTCMKTS:RDGL) Stock Price Down 0.2% - Time to Sell?June 5, 2025 | marketbeat.comShort Interest in Vivos Inc. (OTCMKTS:RDGL) Decreases By 99.3%May 30, 2025 | marketbeat.comVivos Inc. Certifies University of Florida Veterinary Hospital for IsoPet® Precision Radionuclide Therapy™May 15, 2025 | globenewswire.comVivos Inc.May 8, 2025 | marketwatch.comVivos Inc. Achieves Record Growth in IsoPet® Animal Cancer Treatments in Q1 2025April 23, 2025 | globenewswire.comVivos Inc. Reports Continued Progress in India Human Clinical Trial for RadioGel® Precision Radionuclide Therapy™April 15, 2025 | globenewswire.comVivos Inc. Reports Encouraging Human Clinical Trial Results and Announces Expansion PlansFebruary 4, 2025 | finance.yahoo.comVivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics NationwideDecember 27, 2024 | markets.businessinsider.comVivos Inc.'s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics NationwideDecember 26, 2024 | globenewswire.comVivos Inc. Announces Launch of Groundbreaking RadioGel® Precision Radionuclide Therapy™ Human Clinical TrialDecember 23, 2024 | globenewswire.comVivos Therapeutics eyes positive cash flow as it continues cost-reduction success in Q3November 14, 2024 | proactiveinvestors.comVivos Inc. Certifies New Clinic for IsoPet® Precision Radionuclide TherapyTMOctober 18, 2024 | globenewswire.comVivos Inc. Extended its IsoPet® Precision Radionuclide TherapyTM to ExoticsSeptember 30, 2024 | finance.yahoo.comVivos Inc. (RDGL) Stock Price, News, Quote & History - Yahoo FinanceAugust 25, 2024 | finance.yahoo.comVivos Inc. Provides IDE Submission Status Update – Conversion to Pre-Sub Filing Accepted by the FDAJuly 29, 2024 | globenewswire.comVivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical TrialsJune 28, 2024 | globenewswire.comVivos Inc. (RDGL) Latest Stock News & Headlines - Yahoo FinanceMay 15, 2024 | finance.yahoo.comBarchart’s Hot Penny Stocks Screener Identifies Opportunity in Vivos (RDGL)May 3, 2024 | msn.comVivos Inc. (RDGL)April 27, 2024 | finance.yahoo.comVivos Inc RDGLApril 14, 2024 | morningstar.comMVivos Therapeutics, Inc: Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare ReimbursementApril 11, 2024 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHYBT, HYPR, RDGL, and ICCM Company DescriptionsHeyu Biological Technology OTCMKTS:HYBT$0.14 0.00 (0.00%) As of 06/26/2025Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.Hyperfine NASDAQ:HYPR$0.74 +0.01 (+1.42%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$0.74 -0.01 (-0.76%) As of 06/27/2025 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.IceCure Medical NASDAQ:ICCM$1.01 -0.01 (-0.49%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$1.03 +0.02 (+1.58%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.Advanced Medical Isotope OTCMKTS:RDGL$0.12 +0.00 (+0.84%) As of 06/27/2025 03:58 PM EasternVivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Addition by Subtraction: Intel’s New Strategy Energizes Investors NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside QuantumScape Soars 30%: What Drove the Next-Gen EV Stock's Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
